Living Legends

Susan Orloff, United States

Lecture Title: Zen and the Art of Liver Transplantation: What defines quality?

Thursday, 16 May 2024
10:30 - 11:00hrs

Susan L. Orloff, MD, FACS, FAASLD is Professor of Surgery, Division of Abdominal Organ Transplantation/Hepatobiliary Surgery, Adjunct Professor, Department of Molecular Microbiology & Immunology at OHSU, is an internationally recognized leader in liver transplantation/hepatobiliary surgery, and has been Fellowship Director of OHSU’s AHPBA-Accredited HPB Fellowship Program since 2012. She was Chief of the Division from 2008-April 2023.

She attended medical school, internship in internal medicine, and then embarked on a career in surgery at UCSF  via a general surgery residency, and was awarded an NIH research training grant. Following GS residency, she pursued a multi-organ transplantation fellowship at UCSF. In 1995, she was recruited to Oregon Health & Sciences University (OHSU), and Portland VA Medical Center in the Division of Abdominal Organ Transplantation/ Hepatobiliary Surgery.  She was Director of the Portland VA Transplant Program from 2009-2018.  She has a busy clinical practice in abdominal multi-organ transplantation/hepatobiliary surgery.

Dr. Orloff’s clinical research interests include epidemiology/screening/ treatments/genomics of HCC, and other facets of liver transplantation. She runs an NIH-funded laboratory with continuous NIH and/or VA Merit Review funding for 26 years, studying immunologic tolerance, and mechanisms/genomics of CMV-accelerated allograft rejection in heart and kidney transplant rodent models. She was previously Vice-Chair of Research for the Department of Surgery at OHSU.  

Dr. Orloff has served on numerous institutional/local/regional/national/international committees and societies. She has authored over 130 peer-reviewed scientific articles, 25 book chapters, and served as Co-editor for a HPB/Transplantation Textbook, and is on the editorial board of 3 journals.

Dr. Orloff’s commitment to the future of transplantation in the US and globally is foremost in her values and mission, as the transplant community navigates optimizing and expanding the pool of potential donors, as well as determining best strategies to minimize disparities in access to organ transplantation, optimizing outcomes and life years benefit.

Roberto Salvia, Italy
Living Legend Tribute to Claudio Bassi 

Lecture Title: Learn and Teach Pancreatic Surgery: Yesterday...and Today?

Friday 17 May 2024
10:30 - 11:00hrs

Current Position:
Chief of "Pancreatic Surgery" Unit, Hospital Trust (Verona, Italy)
Full Professor of Surgery at the Department of Surgery, Dentistry, Paediatrics and Gynaecology, Verona University
Executive Chief of Verona Pancreas Institute  

Scientific Profile:
Clinical Practice: Renewed abdominal surgeon for over 30 years with specific interest in pancreatic, biliary and hepatic surgery (More than 3000 pancreatic resections as 1st surgeon, educator, co-surgeon and assistant).
Co-author of the Fukuoka international guidelines on the management of IPMNs and organizer of multiple congresses and meetings on pancreatic surgery and pancreatic pathology.

Clinical Research:
Focused on exocrine and endocrine pancreatic neoplasms, with a specific interest on pancreatic cystic neoplasms of pancreas and their management. Co-authors of several papers on genetic of pancreatic tumours published on high impact journals. Principal Investigator of several clinical ongoing project at Verona Pancreas Institute.

Professor of several courses on abdominal surgery at Verona University, heading clinical and educational supervision of surgical trainee of the residency program in General Surgery at Verona University, where he tutored more than 2000 surgical operations.
Promoter and creator of the Master's degree in Palliative Care at Verona University.

Director of the residency program in General Surgery.

Bibliometric Indicators:
# Publications: 451;
# Citations: 33536;
# H index: 68

Palepu Jagannath, India

Lecture Title: Beyond the Ivory Towers - Developing HPB Surgery in Low Middle Income Countries

Saturday, 18 May 2024
10:30 - 11:00hrs

Dr. Jagannath, a pioneer HPB cancer surgeon, is currently Chairman, Department of Surgical Oncology, Lilavati Hospital and Research Centre, and S.L. Raheja Hospital, Mumbai, India.

Dr. Jagannath was instrumental in the growth of HPB surgery in India. He founded the Indian Chapter of IHPBA and was its Secretary (2001) and President (2007). He was President of the A-PHPBA from 2011-2013. He worked with various countries in the Asia-Pacific region to initiate collaborative programs for training in HPB surgery. His efforts in taking HPB surgery courses to second-tier cities have resulted in the spread of HPB surgery across India.

Dr. Jagannath has been involved in IHPBA since the inaugural congress in Boston in 1994. He was a Council member from 2002 and was Chairman of the 8th IHPBA World Congress of IHPBA in 2008 in Mumbai, India, which is still remembered as a landmark congress. He served as President-Elect, President and Past-President of IHPBA during the period 2012 - 2018.

Dr. Jagannath is well recognized for the significant milestones achieved during his term as IHPBA President. He was instrumental in completing the ‘harmonization’ of IHPBA with AHPBA, E-AHPBA and A-PHPBA. Combined membership created a large, united, global organization. ‘The collaborative model’ introduced effective co-ordination between the IHPBA Management Company and LOC for the smooth delivery of the World Congress. The scientific program was modernized and standardized with e-submissions and e-program modules. The ‘Members First’ initiative ensured that all members can benefit from discounted registrations at regional congresses. The ‘IHPBA Foundation’ was incorporated, expanding the scope of the Kenneth Warren Foundation to cover education, research and outreach as well as the Warren Fellowship. ‘’ turned multilingual with regional and national education modules added.

Dr. Jagannath is passionate about promoting outreach programs to developing countries, initiating programs in Nepal, Sri Lanka, Indonesia and Bhutan. He has also been instrumental in setting up ‘Skill Centres’ in Nepal, Sri Lanka and Bhutan for capacity building to improve patient care and ensure safe HPB surgeries. In Nepal, now there are many HPB centres and there is a significant improvement in the quality of service to the patients. Similar efforts have started in Cambodia.

During his presidency, many chapters including Nepal, Sri Lanka, Indonesia, Philippines and MENA were launched. Support for lower resource countries, such as travel grants for the World Congress, was introduced. Under his leadership, IHPBA underwent significant ‘transformation and globalization’.

Currently he is the clinical lead of the “First Cancer care “project of the World Economic Forum.  A white paper was published in 2022 on the use of emerging technologies like AI, ML, iOT and point of care devices to provide quality cancer care. Pilot projects in remote areas of India are started and Digital transformation of cancer care is happening under his leadership. Latest technologies of Immersive reality like ‘Hololens’ are being tested for telementoring.

Dr. Jagannath is well known for his community service. In 2000, he started ‘’ for cancer awareness and public education and established a Charitable Trust ‘Crusade Against Cancer Foundation’ extending financial assistance to cancer afflicted children. The effort is being scaled up as “Cancer Care Consortium’ to provide accessible and affordable cancer care to all.

Recognising his contributions, International Hepato-Pancreato Biliary Association  awarded him the 2020 IHPBA Distinguished Service Medal.

By providing mentoring and skill development to low resource countries, the inequalities in quality of HPB surgery across the world, particularly in low resource countries would be reduced. This should be an important goal for IHPBA.